Project/Area Number |
23659327
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Hygiene
|
Research Institution | Mie University |
Principal Investigator |
MURATA Mariko 三重大学, 大学院・医学系研究科, 教授 (10171141)
|
Co-Investigator(Kenkyū-buntansha) |
MIDORIKAWA Kaoru 三重大学, 大学院・医学系研究科, リサーチアソシエイト (20393366)
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2011: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 炎症 / 上咽頭癌 / microRNA / ターゲット遺伝子 / バイオマーカー / Epstein-Barrウィルス / 発がん機構 / In silico 解析 / microRNA機能解析 / Epstein-Barr ウィルス / DNAメチル化 / マイクロアレイ解析 / 次世代シークエンサー |
Research Abstract |
Epstein-Barr virus-associated nasopharyngeal carcinoma (NPC) is one of the inflammation-associated cancers. To explore the mechanisms of NPC development and certain biomarkers for screening, a microarray profiling survey was performed to reveal the expression patterns of microRNAs across primary tumors (NPC) and normal nasopharyngeal epithelia (NNE). Quantitative real-time PCR confirmed that expression levels of the microRNAs were significantly different between NPC and NNE tissues. Several microRNAs also have significant differences in plasma samples. Up- and down-regulated microRNAs may play a role in NPC development and there is a possibility to use as biomarkers and novel targets for NPC treatment.
|